<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Clindamycin (topical): Pediatric drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Clindamycin (topical): Pediatric drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Clindamycin (topical): Pediatric drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_general" data-topicid="9065" href="/d/html/9065.html" rel="external">see "Clindamycin (topical): Drug information"</a> and <a class="drug drug_patient" data-topicid="11605" href="/d/html/11605.html" rel="external">see "Clindamycin (topical): Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F8008024"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Cleocin;</li>
<li>Cleocin-T;</li>
<li>Clindacin;</li>
<li>Clindacin ETZ;</li>
<li>Clindacin Pac [DSC];</li>
<li>Clindacin-P;</li>
<li>Clindagel;</li>
<li>Clindesse;</li>
<li>Evoclin [DSC];</li>
<li>Xaciato</li></ul></div>
<div class="list canbnlist drugH1Div drugBrandNames" id="F52869089"><span class="drugH1">Brand Names: Canada</span>
<ul>
<li>Clinda-T;</li>
<li>Dalacin T [DSC];</li>
<li>Dalacin Vaginal;</li>
<li>TARO-Clindamycin</li></ul></div>
<div class="list_set htclist drugH1Div drugBrandNames" id="F10533130"><span class="drugH1">Therapeutic Category</span>
<ul>
<li>
<span class="list-set-name">Acne Products</span>;</li>
<li>
<span class="list-set-name">Antibiotic, Anaerobic</span>;</li>
<li>
<span class="list-set-name">Antibiotic, Miscellaneous</span></li></ul></div>
<div class="block dop drugH1Div" id="F8008108"><span class="drugH1">Dosing: Pediatric</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="a14813b8-cfac-43a7-8cfe-083e79bea0fc">Acne vulgaris</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Acne vulgaris:</b>
<b>Note: </b>Due to emerging resistance patterns, should not typically be used as monotherapy for the management of acne vulgaris (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-23637225','lexi-content-ref-26897386']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-23637225','lexi-content-ref-26897386'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Children ≥7 years and Adolescents: Limited data available in &lt;12 years of age (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-23637225']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-23637225'])">Ref</a></span>):</p>
<p style="text-indent:-2em;margin-left:6em;">Gel (Clindagel), Foam (Evoclin): Topical: Apply to affected area once daily.</p>
<p style="text-indent:-2em;margin-left:6em;">Gel (Cleocin T), pledget, lotion, solution: Topical: Apply a thin film twice daily.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="f74ecf56-4df6-48d7-b60e-9165458d8fec">Bacterial vaginosis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Bacterial vaginosis: </b>
<b>Note: </b>The 7-day vaginal cream regimen is preferred (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-34292926','lexi-content-ref-AAP.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-34292926','lexi-content-ref-AAP.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Cream 2%:</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>7-day regimen: </i>Cleocin: Children weighing ≥45 kg and Adolescents: Limited data available: Intravaginal: One full applicator (5 g) once daily at bedtime for 7 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-34292926','lexi-content-ref-AAP.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-34292926','lexi-content-ref-AAP.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>1-day regimen: </i>Clindesse: Adolescents: Intravaginal: One full applicator (5 g) once as a single dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-34292926','lexi-content-ref-Manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-34292926','lexi-content-ref-Manu.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Suppository: Adolescents: Intravaginal: One ovule (100 mg clindamycin) once daily at bedtime for 3 days.</p></div>
</div>
</div>
<div class="block dorp drugH1Div" id="F51089936"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling; however, no dosage adjustments are required with systemic clindamycin use.</p></div>
<div class="block dohp drugH1Div" id="F51089937"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling; however, no dosage adjustments are required with systemic clindamycin use; use caution with severe hepatic impairment.</p></div>
<div class="block doa drugH1Div" id="F8008109"><span class="drugH1">Dosing: Adult</span><p>(For additional information <a class="drug drug_general" data-topicid="9065" href="/d/html/9065.html" rel="external">see "Clindamycin (topical): Drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="a14813b8-cfac-43a7-8cfe-083e79bea0fc">Acne vulgaris</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Acne vulgaris:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note: </b>Use in combination with benzoyl peroxide to reduce the risk for the development of antibiotic resistance (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-26897386','lexi-content-ref-Graber.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-26897386','lexi-content-ref-Graber.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Topical:</b></p>
<p style="text-indent:-2em;margin-left:6em;">Gel (Cleocin T, ClindaMax), pledget, lotion, solution: Apply a thin film twice daily.</p>
<p style="text-indent:-2em;margin-left:6em;">Gel (Clindagel), foam (Evoclin): Apply once daily.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="f74ecf56-4df6-48d7-b60e-9165458d8fec">Bacterial vaginosis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Bacterial vaginosis:</b>
<i></i></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note: </b>Treatment is generally not warranted for patients who are asymptomatic. When treatment is given, the 7-day regimen is preferred (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-34292926']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-34292926'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">2% cream (Cleocin): <b>Intravaginal:</b> One applicatorful (5 g containing ~100 mg clindamycin) once daily at bedtime for 7 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-34292926']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-34292926'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">2% cream (Clindesse) (alternative agent): <b>Intravaginal:</b> One applicatorful (5 g containing ~100 mg clindamycin) once as a single dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-34292926','lexi-content-ref-16240515']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-34292926','lexi-content-ref-16240515'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">2% gel (Xaciato) (alternative agent): <b>Intravaginal:</b> One applicatorful (5 g containing 100 mg clindamycin) once as a single dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-34292926','lexi-content-ref-35675606']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-34292926','lexi-content-ref-35675606'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">100 mg suppository (alternative agent): <b>Intravaginal:</b> One suppository once daily at bedtime for 3 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-34292926']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-34292926'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="a1a5c771-d06c-4f42-a40c-2a0c6db81cba">Hidradenitis suppurativa</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Hidradenitis suppurativa (off-label use):</b> Solution: <b>Topical: </b>Apply to affected area twice daily (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-22236226']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-22236226'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="cc3a2a3a-842f-4019-92f3-0d78d87a74b9">Rosacea</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Rosacea (off-label use):</b> Lotion: <b>Topical:</b> Apply twice daily to the face (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-8425809']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-8425809'])">Ref</a></span>).</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50990632"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doha drugH1Div" id="F50987644"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block adr drugH1Div" id="F8008056"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified. Adverse reactions reported in adolescents and adults.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Topical:</b></p>
<p style="text-indent:-2em;margin-left:2em;">&gt;10%:</p>
<p style="text-indent:-2em;margin-left:4em;">Dermatologic: Burning sensation of skin (10% to 11%), erythema of skin (7% to 16%), exfoliation of skin (7% to 11%), oily skin (1% to 18%), pruritus (7% to 11%)</p>
<p style="text-indent:-2em;margin-left:4em;">Local: Local dryness of skin (application-site: 1% to 23%)</p>
<p style="text-indent:-2em;margin-left:2em;">1% to 10%:</p>
<p style="text-indent:-2em;margin-left:4em;">Local: Application-site burning (6%), application-site pruritus (1%)</p>
<p style="text-indent:-2em;margin-left:4em;">Nervous system: Headache (3%)</p>
<p style="text-indent:-2em;margin-left:2em;margin-top:2em;">
<b>Intravaginal:</b></p>
<p style="text-indent:-2em;margin-left:2em;">&gt;10%: Genitourinary: Vaginitis (≤11%; including trichomonal vulvovaginitis [1%], vaginal discharge, vaginal infection, vulvovaginal disease, and vulvovaginitis [4% to 6%]), vulvovaginal candidiasis (2% to 14%)</p>
<p style="text-indent:-2em;margin-left:2em;">1% to 10%:</p>
<p style="text-indent:-2em;margin-left:4em;">Gastrointestinal: Constipation (2%)</p>
<p style="text-indent:-2em;margin-left:4em;">Genitourinary: Urinary tract infection (2%), vaginal pain (2%)</p>
<p style="text-indent:-2em;margin-left:4em;">Infection: Candidiasis (≤3%), fungal infection (≤1%)</p>
<p style="text-indent:-2em;margin-left:4em;">Nervous system: Headache (7%)</p>
<p style="text-indent:-2em;margin-left:4em;">Neuromuscular &amp; skeletal: Back pain (5%)</p>
<p style="text-indent:-2em;margin-left:2em;">&lt;1%:</p>
<p style="text-indent:-2em;margin-left:4em;">Dermatologic: Cutaneous candidiasis, erythema of skin, maculopapular rash, pruritic rash, pruritus, skin rash, urticaria</p>
<p style="text-indent:-2em;margin-left:4em;">Endocrine &amp; metabolic: Hyperthyroidism, intermenstrual bleeding, menstrual disease</p>
<p style="text-indent:-2em;margin-left:4em;">Gastrointestinal: Abdominal cramps, abdominal pain, diarrhea, dysgeusia, dyspepsia, flatulence, halitosis, nausea, vomiting</p>
<p style="text-indent:-2em;margin-left:4em;">Genitourinary: Dysmenorrhea, dysuria, endometriosis, pelvic pain, uterine hemorrhage (including abnormal uterine bleeding), vaginal discomfort, vaginal dryness, vaginal irritation, vulvitis, vulvovaginal burning, vulvovaginal pruritus</p>
<p style="text-indent:-2em;margin-left:4em;">Hypersensitivity: Hypersensitivity reaction</p>
<p style="text-indent:-2em;margin-left:4em;">Infection: Bacterial infection</p>
<p style="text-indent:-2em;margin-left:4em;">Local: Application-site erythema (vaginal)</p>
<p style="text-indent:-2em;margin-left:4em;">Nervous system: Dizziness, fatigue, pain, vertigo</p>
<p style="text-indent:-2em;margin-left:4em;">Renal: Flank pain, pyelonephritis</p>
<p style="text-indent:-2em;margin-left:4em;">Respiratory: Epistaxis</p>
<p style="text-indent:-2em;margin-left:4em;">Miscellaneous: Fever</p>
<p style="text-indent:-2em;margin-left:2em;margin-top:2em;">
<b>Postmarketing (any formulation):</b></p>
<p style="text-indent:-2em;margin-left:4em;">Dermatologic: Contact dermatitis, folliculitis, seborrhea, skin irritation, skin pain</p>
<p style="text-indent:-2em;margin-left:4em;">Gastrointestinal: Bloody diarrhea, <i>Clostridioides difficile</i> colitis, colitis, hematochezia</p>
<p style="text-indent:-2em;margin-left:4em;">Genitourinary: Vaginal hemorrhage</p>
<p style="text-indent:-2em;margin-left:4em;">Local: Application-site rash, local swelling (vaginal)</p>
<p style="text-indent:-2em;margin-left:4em;">Ophthalmic: Eye pain</p></div>
<div class="block coi drugH1Div" id="F8008043"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;margin-left:0em;display:inline">Hypersensitivity to clindamycin, lincomycin, or any component of the formulation; history of antibiotic-associated colitis, regional enteritis, ulcerative colitis.</p></div>
<div class="block war drugH1Div" id="F8008054"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Colitis: Use may result in fungal or bacterial superinfection, including <i>Clostridioides difficile</i>-associated diarrhea (CDAD); CDAD has been observed &gt;2 months postantibiotic treatment. Discontinue drug if significant diarrhea, abdominal cramps, or passage of blood and mucus occurs.</p>
<p style="text-indent:-2em;margin-left:4em;">• Superinfection: The use of clindamycin may result in the overgrowth of nonsusceptible organisms, particularly yeasts, in the vagina. Treatment-related moniliasis and vaginitis have been reported.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Special populations:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Atopic patients: Use with caution in atopic patients.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Dosage form specific issues:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Benzyl alcohol and derivatives: Some dosage forms may contain benzyl alcohol; large amounts of benzyl alcohol (≥99 mg/kg/day) have been associated with a potentially fatal toxicity (“gasping syndrome”) in neonates; the “gasping syndrome” consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension and cardiovascular collapse (AAP ["Inactive" 1997]; CDC 1982); some data suggests that benzoate displaces bilirubin from protein binding sites (Ahlfors 2001); avoid or use dosage forms containing benzyl alcohol with caution in neonates. See manufacturer’s labeling.</p>
<p style="text-indent:-2em;margin-left:4em;">• Topical foam: Topical foam may cause irritation especially when used with abrasive, desquamating or peeling agents; avoid contact with eyes, mouth, lips, mucous membranes, or broken skin.</p>
<p style="text-indent:-2em;margin-left:4em;">• Topical pledget or solution: Topical pledget and topical solution contain an alcohol base and may cause eye irritation or burning. Rinse with cool tap water if product comes in contact with mucous membranes, abraded skin, or eyes. Use caution when applying near mouth (unpleasant taste).</p>
<p style="text-indent:-2em;margin-left:4em;">• Vaginal products: May weaken condoms, or contraceptive diaphragms; barrier contraceptives are not recommended concurrently or for 3 to 7 days (depending on the product) following treatment. Avoid vaginal intercourse or use of other vaginal products (eg, douches, tampons) during therapy (Cleocin, Clinedess, Xaciato) and for 3 days after therapy (Xaciato). Vaginal cream contains ingredients that may cause eye burning and irritation; rinse with cool tap water if product comes in contact with the eyes.</p>
<p style="text-indent:-2em;margin-left:2em;">
<i>
<b>Other warnings/precautions:</b></i></p>
<p style="text-indent:-2em;margin-left:4em;">• Appropriate use: Acne: American Academy of Dermatology (AAD) acne guidelines recommend clindamycin (topical) be used in conjunction with other therapies (<i>not</i> as monotherapy) due to the risk of bacterial resistance. If given for mild acne, clindamycin (topical) should be used in combination with benzoyl peroxide. If given for moderate to severe acne, it should be used in combination with a topical retinoid or systemic antibiotic agent (AAD [Zaenglein 2016]).</p></div>
<div class="block add-pediatric-warn-info drugH1Div" id="F52878729"><span class="drugH1">Warnings: Additional Pediatric Considerations</span>
<p style="text-indent:0em;display:inline">Some dosage forms may contain propylene glycol; in neonates large amounts of propylene glycol delivered orally, intravenously (eg, &gt;3,000 mg/day), or topically have been associated with potentially fatal toxicities which can include metabolic acidosis, seizures, renal failure, and CNS depression; toxicities have also been reported in children and adults including hyperosmolality, lactic acidosis, seizures and respiratory depression; use caution (AAP 1997; Shehab 2009).</p></div>
<div class="block foc drugH1Div" id="F8008157"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Cream, Vaginal, as phosphate [strength expressed as base]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Cleocin: 2% (40 g) [contains benzyl alcohol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Clindesse: 2% (5 g) [contains disodium edta, methylparaben, propylparaben]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 2% (40 g)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Foam, External, as phosphate [strength expressed as base]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Clindacin: 1% (100 g) [contains cetyl alcohol, propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Evoclin: 1% (50 g [DSC], 100 g [DSC]) [contains alcohol, usp, cetyl alcohol, propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 1% (50 g, 100 g)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Gel, Vaginal: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Xaciato: 2% (5 g) [contains benzyl alcohol]</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Gel, External, as phosphate [strength expressed as base]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Cleocin-T: 1% (30 g, 60 g) [contains methylparaben, propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Clindagel: 1% (75 mL) [contains methylparaben, polyethylene glycol (macrogol), propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 1% (30 g, 60 g, 75 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Kit, External, as phosphate [strength expressed as base]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Clindacin ETZ: 1% [contains cetyl alcohol, isopropyl alcohol, propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Clindacin Pac: 1% [DSC] [contains cetyl alcohol, isopropyl alcohol, propylene glycol]</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Lotion, External, as phosphate [strength expressed as base]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Cleocin-T: 1% (60 mL) [contains cetostearyl alcohol, methylparaben]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 1% (60 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, External, as phosphate [strength expressed as base]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 1% (30 mL, 60 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Suppository, Vaginal, as phosphate [strength expressed as base]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Cleocin: 100 mg (3 ea)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Swab, External, as phosphate [strength expressed as base]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Clindacin ETZ: 1% (60 ea) [contains isopropyl alcohol, propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Clindacin-P: 1% (69 ea) [contains isopropyl alcohol, propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 1% (60 ea)</p></div>
<div class="block geq drugH1Div" id="F8008027"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">May be product dependent</p></div>
<div class="block fee drugH1Div" id="F8008159"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Cream</b> (Cleocin Vaginal)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">2% (per gram): $6.03</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Cream</b> (Clindamycin Phosphate Vaginal)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">2% (per gram): $2.72 - $3.26</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Cream</b> (Clindesse Vaginal)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">2% (per gram): $33.40</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Foam</b> (Clindacin External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1% (per gram): $5.45</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Foam</b> (Clindamycin Phosphate External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1% (per gram): $4.80 - $6.93</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Gel</b> (Clindagel External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1% (per mL): $28.44</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Gel</b> (Clindamycin Phosphate External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1% (per gram): $0.80 - $3.46</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Gel</b> (Xaciato Vaginal)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">2% (per gram): $36.00</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Kit</b> (Clindacin ETZ External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1% (per each): $774.68</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Lotion</b> (Cleocin-T External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1% (per mL): $2.34</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Lotion</b> (Clindamycin Phosphate External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1% (per mL): $1.92 - $2.40</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Solution</b> (Clindamycin Phosphate External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1% (per mL): $0.33 - $1.36</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Suppository</b> (Cleocin Vaginal)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">100 mg (per each): $73.50</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Swab</b> (Clindacin ETZ External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1% (per each): $12.91</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Swab</b> (Clindacin-P External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1% (per each): $11.83</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Swab</b> (Clindamycin Phosphate External)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">1% (per each): $0.84</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block dinfoc drugH1Div" id="F52869090"><span class="drugH1">Dosage Forms: Canada</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Cream, Vaginal, as phosphate [strength expressed as base]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Dalacin Vaginal: 2% (40 g) [contains benzyl alcohol, propylene glycol]</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Solution, External, as phosphate [strength expressed as base]: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Clinda-T: 1% (30 mL, 60 mL) [contains isopropyl alcohol, propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Dalacin T: 1% ([DSC]) [contains alcohol, usp, propylene glycol]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 1% (30 mL, 60 mL)</p></div>
<div class="block admp drugH1Div" id="F52614327"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:-2em;margin-left:2em;">Intravaginal: Do not use for topical therapy, instillation in the eye, or oral administration. Wash hands prior to use.</p>
<p style="text-indent:-2em;margin-left:4em;">Cream: Fill applicator with cream, then insert into vagina as far as possible without causing discomfort; expel cream. Use each disposable applicator only once; discard applicator after use.</p>
<p style="text-indent:-2em;margin-left:4em;">Suppository: Remove from packaging; if applicator is used for administration, place suppository into applicator and insert applicator into vagina as far as possible without causing discomfort and expel suppository. Patient should lie down after administration to minimize leakage. Wash applicator with soap and water.</p>
<p style="text-indent:-2em;margin-left:2em;">Topical: For dermal topical use only. Do not use intravaginally, instill in the eye, or administer orally. Avoid contact with eyes, mouth, lips, mucous membranes, or broken skin.</p>
<p style="text-indent:-2em;margin-left:4em;">Foam: Before applying foam, wash affected area with mild soap, then dry. Remove cap, hold can at an upright angle, and dispense foam directly into the cap or onto a cool surface; do not dispense foam directly onto hands or face (foam will melt upon contact with warm skin). If can is warm or foam is runny, run can under cold water. Use fingertips to pick up small amounts of foam and gently massage into affected area until foam disappears. Wash hands after applying. Avoid fire, flame, or smoking during or immediately following application.</p>
<p style="text-indent:-2em;margin-left:4em;">Gel, pledget, solution: Solution/pledget contains an alcohol base and if inadvertent contact with mucous membranes occurs, rinse with liberal amounts of water. Remove pledget from foil immediately before use; discard after single use. May use more than one pledget for each application to cover area.</p>
<p style="text-indent:-2em;margin-left:4em;">Lotion: Shake well immediately before use; apply topically.</p></div>
<div class="block adm drugH1Div" id="F8008123"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Intravaginal:</b></p>
<p style="text-indent:-2em;margin-left:4em;">Cream: Insertion with the applicator should be as far as possible into the vagina without causing discomfort.</p>
<p style="text-indent:-2em;margin-left:4em;">Gel: Not for ophthalmic, dermal, or oral use. Use applicator for insertion.</p>
<p style="text-indent:-2em;margin-left:4em;">Suppository: Remove from packaging prior to use. If applicator is used for administration, insertion should be as far as possible into the vagina without causing discomfort; wash applicator after each use. Patient should lie down after administration to minimize leakage.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Topical:</b></p>
<p style="text-indent:-2em;margin-left:4em;">Foam: Dispense directly into cap or onto a cool surface; do not dispense directly into hands or face (foam will melt on contact with warm skin). Wash skin with mild soap and allow to fully dry. Apply in small amounts to face using fingertips and gently massage into affected areas until foam disappears. Avoid contact with eyes, mouth, lips, mucous membranes, or broken skin.</p>
<p style="text-indent:-2em;margin-left:4em;">Gel: Avoid contact with eyes.</p>
<p style="text-indent:-2em;margin-left:4em;">Lotion: Shake well immediately before using.</p>
<p style="text-indent:-2em;margin-left:4em;">Solution or pledget: Avoid contact with eyes, mouth or other mucous membranes; solution/pledget contains an alcohol base and if inadvertent contact with mucous membranes occurs, rinse with liberal amounts of water. Remove pledget from foil immediately before use; discard after single use. May use more than one pledget for each application to cover area.</p></div>
<div class="block sts drugH1Div" id="F8008075"><span class="drugH1">Storage/Stability</span>
<p style="text-indent:-2em;margin-left:2em;">Cream: Store at 20°C to 25°C (68°F to 77°F). Protect from freezing.</p>
<p style="text-indent:-2em;margin-left:2em;">Foam: Store at 20°C to 25°C (68°F to 77°F). Avoid fire, flame, or smoking during or immediately following application. Do not puncture or incinerate container. Do not expose to heat or store at temperatures &gt;49°C (120°F).</p>
<p style="text-indent:-2em;margin-left:2em;">Gel: Store at 20°C to 25°C (68°F to 77°F). Protect from freezing.</p>
<p style="text-indent:-2em;margin-left:4em;">Clindagel: Do not store in direct sunlight.</p>
<p style="text-indent:-2em;margin-left:4em;">Xaciato: Excursions are permitted to 15°C to 30°C (59°F to 86°F).</p>
<p style="text-indent:-2em;margin-left:2em;">Lotion: Store at 20°C to 25°C (68°F to 77°F). Protect from freezing.</p>
<p style="text-indent:-2em;margin-left:2em;">Pledget: Store at 20°C to 25°C (68°F to 77°F). Protect from freezing.</p>
<p style="text-indent:-2em;margin-left:2em;">Suppository: Store at 25°C (77°F); excursions are permitted to 15°C to 30°C (59°F to 86°F). Avoid heat &gt;30°C (86°F) and high humidity.</p>
<p style="text-indent:-2em;margin-left:2em;">Topical solution: Store at 20°C to 25°C (68°F to 77°F). Protect from freezing.</p></div>
<div class="block usep drugH1Div" id="F53570451"><span class="drugH1">Use</span>
<p style="text-indent:-2em;margin-left:2em;">Topical: Foam, gel, lotion, pledget, solution: Treatment of acne vulgaris (FDA approved in ages ≥12 years and adults).</p>
<p style="text-indent:-2em;margin-left:2em;">Vaginal: Treatment of bacterial vaginosis in the following ages:</p>
<p style="text-indent:-2em;margin-left:4em;">Cleocin Ovules, Clindesse Vaginal Cream: FDA approved in postmenarchal adolescents and adults.</p>
<p style="text-indent:-2em;margin-left:4em;">Cleocin Vaginal Cream: FDA approved in adults.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Note</b>
<b>:</b> Approved ages and uses for generic products may vary; consult labeling for specific information.</p></div>
<div class="block mst drugH1Div" id="F8007985"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">Sound-alike/look-alike issues:</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">Cleocin may be confused with bleomycin, Clinoril, Cubicin, Lincocin</p>
<p style="text-indent:-2em;margin-left:4em;">Clindamycin may be confused with clarithromycin, Claritin, vancomycin</p>
<p style="text-indent:-2em;margin-left:4em;">Clindesse may be confused with Clindets</p></div>
</div>
</div>
<div class="block cyt drugH1Div" id="F13299058"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F8018207"><span class="drugH1">Drug Interactions</span><br/><br/><div class="clear"></div><p xmlns=""></p><div class="inner" xmlns=""><p style="text-indent:0em;display:inline"><b>Note</b>: Interacting drugs may <b>not be individually listed below</b> if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed).  For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program by clicking on the “Launch drug interactions program” link above.</p><p xmlns=""></p></div>
<p style="text-indent:-2em;margin-left:2em;">Erythromycin (Systemic): May diminish the therapeutic effect of Clindamycin (Topical). Management: Consider avoiding the concomitant use of systemic erythromycin and topical clindamycin when treating acne vulgaris. This recommendation does not appear to apply to intravaginal use of clindamycin for the treatment of bacterial vaginosis.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Erythromycin (Topical): May diminish the therapeutic effect of Clindamycin (Topical). Management: Consider avoiding use of topical erythromycin and topical clindamycin at the same application site when treating acne vulgaris. This recommendation does not appear to apply to intravaginal use of clindamycin for the treatment of bacterial vaginosis.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Neuromuscular-Blocking Agents: Clindamycin (Topical) may enhance the neuromuscular-blocking effect of Neuromuscular-Blocking Agents. <i> Risk C: Monitor therapy</i></p></div>
<div class="block rep_considerations drugH1Div" id="F49296633"><span class="drugH1">Reproductive Considerations</span>
<p style="text-indent:0em;">Some vaginal products contain mineral oil which may weaken condoms or contraceptive diaphragms. Therefore, use of these products are not recommended for birth control during therapy or for 3 to 7 days (depending on the product) following treatment.</p></div>
<div class="block pri drugH1Div" id="F9749572"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;">Clindamycin crosses the placenta following oral and parenteral dosing (Philipson 1973; Weinstein 1976). The amount of clindamycin available systemically is less following topical and vaginal application than with IV or oral administration.</p>
<p style="text-indent:0em;margin-top:2em;">Various clindamycin vaginal products are available for the treatment of bacterial vaginosis. Recommendations for use in pregnant patients vary by product labeling. Current guidelines note that the same oral or vaginal regimens used in nonpregnant patients may be used during pregnancy, including oral or vaginal clindamycin (CDC [Workowski 2021]).</p>
<p style="text-indent:0em;margin-top:2em;">If treatment for acne is needed during pregnancy, topical clindamycin may be considered if an antibiotic is needed. To decrease systemic exposure, pregnant women should avoid application to inflamed skin for long periods of time, or to large body surface areas (Kong 2013).</p></div>
<div class="block mopp drugH1Div" id="F53570452"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:0em;display:inline">Observe for changes in bowel frequency.</p></div>
<div class="block pha drugH1Div" id="F8008079"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Reversibly binds to 50S ribosomal subunits preventing peptide bond formation thus inhibiting bacterial protein synthesis; bacteriostatic or bactericidal depending on drug concentration, infection site, and organism</p></div>
<div class="block phk drugH1Div" id="F8008081"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;">Absorption: Topical solution or foam, phosphate: Minimal; Vaginal cream, phosphate: ~5%; Vaginal suppository, phosphate: ~30%</p>
<p style="text-indent:-2em;margin-left:2em;">Metabolism: Hepatic; forms metabolites (variable activity); Clindamycin phosphate is converted to clindamycin HCl (active)</p>
<p style="text-indent:-2em;margin-left:2em;">Half-life elimination: Vaginal cream: 1.5 to 2.6 hours following repeated dosing; Vaginal suppository: 11 hours (range: 4 to 35 hours, limited by absorption rate)</p>
<p style="text-indent:-2em;margin-left:2em;">Time to peak, serum: Vaginal cream: ~10 to 14 hours (range: 4 to 24 hours); Vaginal suppository: ~5 hours (range: 1 to 10 hours)</p>
<p style="text-indent:-2em;margin-left:2em;">Excretion: Urine (&lt;0.2% with topical foam and solution)</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F10961962"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(AE)</span> <span class="country">United Arab Emirates</span><span class="countrySeparator">: </span><span class="drugName">Dalacin | Dalacin c | Dalacin t | Medacin t | Yenlip</span>;</li>
<li>
<span class="countryCode">(AR)</span> <span class="country">Argentina</span><span class="countrySeparator">: </span><span class="drugName">Acnestop | Clindacin | Clindamicina | Clindamicina Biol | Clinfol | Clintopic | Dalacin crema vaginal | Dalacin Ovulos | Front | Torgyn</span>;</li>
<li>
<span class="countryCode">(AT)</span> <span class="country">Austria</span><span class="countrySeparator">: </span><span class="drugName">Dalacin | Zindaclin</span>;</li>
<li>
<span class="countryCode">(AU)</span> <span class="country">Australia</span><span class="countrySeparator">: </span><span class="drugName">Clindamycin | Clindatech | Dalacin t | Dalacin v</span>;</li>
<li>
<span class="countryCode">(BD)</span> <span class="country">Bangladesh</span><span class="countrySeparator">: </span><span class="drugName">Cleocin | Clindacin | Clindax | Clinex | Daclin</span>;</li>
<li>
<span class="countryCode">(BE)</span> <span class="country">Belgium</span><span class="countrySeparator">: </span><span class="drugName">Dalacin | Dalacin Vaginal | Yenlip | Zindaclin</span>;</li>
<li>
<span class="countryCode">(BF)</span> <span class="country">Burkina Faso</span><span class="countrySeparator">: </span><span class="drugName">Aclin</span>;</li>
<li>
<span class="countryCode">(BG)</span> <span class="country">Bulgaria</span><span class="countrySeparator">: </span><span class="drugName">Clindavasin v | Dalacin</span>;</li>
<li>
<span class="countryCode">(BR)</span> <span class="country">Brazil</span><span class="countrySeparator">: </span><span class="drugName">Anaerocid | Clinagel | Clindacne | Dalacin v | Fosfato de Clindamicina</span>;</li>
<li>
<span class="countryCode">(CH)</span> <span class="country">Switzerland</span><span class="countrySeparator">: </span><span class="drugName">Dalacin v</span>;</li>
<li>
<span class="countryCode">(CI)</span> <span class="country">Côte d'Ivoire</span><span class="countrySeparator">: </span><span class="drugName">Aclin</span>;</li>
<li>
<span class="countryCode">(CL)</span> <span class="country">Chile</span><span class="countrySeparator">: </span><span class="drugName">Clidan | Clidets | Clinacnyl | Cluvax | Dalacin Ovulos | Dalacin t | Dalacin v | Dermabel | Divanon</span>;</li>
<li>
<span class="countryCode">(CN)</span> <span class="country">China</span><span class="countrySeparator">: </span><span class="drugName">Da lin | Yan le</span>;</li>
<li>
<span class="countryCode">(CO)</span> <span class="country">Colombia</span><span class="countrySeparator">: </span><span class="drugName">Bexon | Cleocin t | Clidets | Clindamicina | Clindana | Dalacin v | Damicine | Damiclin v | Euroclin V | Gyno baclin | Infex | Nexoclin | Trexen</span>;</li>
<li>
<span class="countryCode">(CZ)</span> <span class="country">Czech Republic</span><span class="countrySeparator">: </span><span class="drugName">Dalacin | Dalacin c | Dalacin t</span>;</li>
<li>
<span class="countryCode">(DE)</span> <span class="country">Germany</span><span class="countrySeparator">: </span><span class="drugName">Basocin | Clindamycin aristo | Sobelin | Zindaclin</span>;</li>
<li>
<span class="countryCode">(DO)</span> <span class="country">Dominican Republic</span><span class="countrySeparator">: </span><span class="drugName">Afuxclin | Andi vagil plus | Clavel | Clidax | Clinda | Clindamicin | Clindamicina | Clindaris | Clindavic | Clinfol | Cliofar | Cutaclin | Dalacin v | Euroclin | Gynobiotic | Vagibiotic</span>;</li>
<li>
<span class="countryCode">(EC)</span> <span class="country">Ecuador</span><span class="countrySeparator">: </span><span class="drugName">Clindacin | Clindamicina | Clindamicina mk | Clindazin | Dalacin v | Divanon | Euroclin | Euroclin V | Ovucin | Vioclin</span>;</li>
<li>
<span class="countryCode">(EE)</span> <span class="country">Estonia</span><span class="countrySeparator">: </span><span class="drugName">Climycen | Dalacin c | Dalacin t | Dalacin v | Sobelin | Vagicin</span>;</li>
<li>
<span class="countryCode">(EG)</span> <span class="country">Egypt</span><span class="countrySeparator">: </span><span class="drugName">Chemocin | Chenaromita | Clinda sol | Clindacine | Clindaval | Clindavert | Clinocid | Dalacin | Feminaxclind | Utoclind | Vagiclind | Vimodame</span>;</li>
<li>
<span class="countryCode">(ES)</span> <span class="country">Spain</span><span class="countrySeparator">: </span><span class="drugName">Clindamicina Aristo | Clinwas | Dalacin</span>;</li>
<li>
<span class="countryCode">(ET)</span> <span class="country">Ethiopia</span><span class="countrySeparator">: </span><span class="drugName">Medacin t | Tidact</span>;</li>
<li>
<span class="countryCode">(FI)</span> <span class="country">Finland</span><span class="countrySeparator">: </span><span class="drugName">Dalacin</span>;</li>
<li>
<span class="countryCode">(FR)</span> <span class="country">France</span><span class="countrySeparator">: </span><span class="drugName">Zindacline</span>;</li>
<li>
<span class="countryCode">(GB)</span> <span class="country">United Kingdom</span><span class="countrySeparator">: </span><span class="drugName">Dalacin | Dalacin t | Zindaclin</span>;</li>
<li>
<span class="countryCode">(GR)</span> <span class="country">Greece</span><span class="countrySeparator">: </span><span class="drugName">Botamycin n | Climycen | Clindagel | Clindamycin target | Esteria | Fouch | Toliken | Vagiclin | Veldom | Velkaderm | Yenlip | Ygielle</span>;</li>
<li>
<span class="countryCode">(HK)</span> <span class="country">Hong Kong</span><span class="countrySeparator">: </span><span class="drugName">Barsueli | Bittle | Bosamin | Claribel | Clindamycin | Clinex | Clingene-t | Clinmax | Cormic | Dalacin t | Eurocin a | Eurotech | Fourcas | Jepster | Kolincin | Lazer | P s d | Pansaric | Pasto | Ramiton | Royalsense | T3 Mycin | Vitara Clinda | Zanifar | Zindaclin</span>;</li>
<li>
<span class="countryCode">(HR)</span> <span class="country">Croatia</span><span class="countrySeparator">: </span><span class="drugName">Dalacin | Klimicin V</span>;</li>
<li>
<span class="countryCode">(HU)</span> <span class="country">Hungary</span><span class="countrySeparator">: </span><span class="drugName">Dalacin | Dalacin t | Zindaclin</span>;</li>
<li>
<span class="countryCode">(ID)</span> <span class="country">Indonesia</span><span class="countrySeparator">: </span><span class="drugName">Cindala | Clidacor | Clinika | Clinium | Daclin acne | Dalacin t | Mediklin | Opiclam</span>;</li>
<li>
<span class="countryCode">(IE)</span> <span class="country">Ireland</span><span class="countrySeparator">: </span><span class="drugName">Dalacin | Dalacin t | Zindaclin</span>;</li>
<li>
<span class="countryCode">(IL)</span> <span class="country">Israel</span><span class="countrySeparator">: </span><span class="drugName">Dalacin | Zindaclin</span>;</li>
<li>
<span class="countryCode">(IN)</span> <span class="country">India</span><span class="countrySeparator">: </span><span class="drugName">Acleen | Aclind | Acloderm | Acne C | Acneclin | Acneris | Acnethro c | Aknarial | Allyte | Clear | Cleargel | Clencin | Clenz | Cliface | Cligel | Climple | Clinagel | Clincent | Clincin | Clincitop | Clincure | Clindac-a | Clinderm | Clindot | Clindy | Clingard | Clinizex | Clinka | Clinlup | Clinmax | Clinof | Clinpeu | Clinred | Clinzit | D'Acne | Erytop | Klinspec | Klynx | Lupin's pim off | Mimosee | Seaglow</span>;</li>
<li>
<span class="countryCode">(IT)</span> <span class="country">Italy</span><span class="countrySeparator">: </span><span class="drugName">Cleocin | Clindamicina same | Clindax | Dalacin t | Zindaclin</span>;</li>
<li>
<span class="countryCode">(JO)</span> <span class="country">Jordan</span><span class="countrySeparator">: </span><span class="drugName">Clindacin | Clinimycin T | Dalacin c | Dalacin t | Fouch</span>;</li>
<li>
<span class="countryCode">(JP)</span> <span class="country">Japan</span><span class="countrySeparator">: </span><span class="drugName">Clindamycin | Clindamycin Dk | Clindamycin Kracie | Clindamycin phosphate Iwaki | Dalacin t</span>;</li>
<li>
<span class="countryCode">(KE)</span> <span class="country">Kenya</span><span class="countrySeparator">: </span><span class="drugName">Clincin | Clindabiox | Clindar t | Clindar v | Pip off</span>;</li>
<li>
<span class="countryCode">(KR)</span> <span class="country">Korea, Republic of</span><span class="countrySeparator">: </span><span class="drugName">Cleand_all | Cleocin | Dongin epigel | Zindaclin</span>;</li>
<li>
<span class="countryCode">(KW)</span> <span class="country">Kuwait</span><span class="countrySeparator">: </span><span class="drugName">Dalacin | Dalacin c | Dalacin t | Medacin t | Vagiclind</span>;</li>
<li>
<span class="countryCode">(LB)</span> <span class="country">Lebanon</span><span class="countrySeparator">: </span><span class="drugName">Cliniderm | Clinimycin T | Dalacin c | Danalli | Medacin t | Zindaclin</span>;</li>
<li>
<span class="countryCode">(LT)</span> <span class="country">Lithuania</span><span class="countrySeparator">: </span><span class="drugName">Dalacin | Sobelin | Zindaclin</span>;</li>
<li>
<span class="countryCode">(LU)</span> <span class="country">Luxembourg</span><span class="countrySeparator">: </span><span class="drugName">Dalacin | Yenlip | Zindaclin</span>;</li>
<li>
<span class="countryCode">(LV)</span> <span class="country">Latvia</span><span class="countrySeparator">: </span><span class="drugName">Dalacin | Dalacin t</span>;</li>
<li>
<span class="countryCode">(MX)</span> <span class="country">Mexico</span><span class="countrySeparator">: </span><span class="drugName">Aktufoam | Biodaclin | Bredafur | Clidets | Clindamicin | Clindamicina | Clindamicina Rayere | Clintopic | Cliran | Codixil | Cutaclin | Dalacin t | Dalacin v | Dalatina | Dalatina t | Dalatina V | Feisclin | Periplum | Sunoplex V | Trexen</span>;</li>
<li>
<span class="countryCode">(MY)</span> <span class="country">Malaysia</span><span class="countrySeparator">: </span><span class="drugName">C mycin | Dalacin t | Dalacin v | T3 Mycin | Tidact | Zindaclin</span>;</li>
<li>
<span class="countryCode">(NL)</span> <span class="country">Netherlands</span><span class="countrySeparator">: </span><span class="drugName">Clindamycine | Dalacin | Dalacin t</span>;</li>
<li>
<span class="countryCode">(NO)</span> <span class="country">Norway</span><span class="countrySeparator">: </span><span class="drugName">Dalacin | Sobelin</span>;</li>
<li>
<span class="countryCode">(NZ)</span> <span class="country">New Zealand</span><span class="countrySeparator">: </span><span class="drugName">Dalacin t | Dalacin v</span>;</li>
<li>
<span class="countryCode">(PE)</span> <span class="country">Peru</span><span class="countrySeparator">: </span><span class="drugName">Clindacin-v | Clindamax | Clindamicina | Clindess | Clindox | Clinfol | Clixdin | Cutaclin | Dalacin t 1% | Dalacin v | Damiciclin | Euroclin V | Nexoclin | Plenaliv</span>;</li>
<li>
<span class="countryCode">(PH)</span> <span class="country">Philippines</span><span class="countrySeparator">: </span><span class="drugName">Akneclin | Clindamycin | Clinderm | T3 Mycin</span>;</li>
<li>
<span class="countryCode">(PK)</span> <span class="country">Pakistan</span><span class="countrySeparator">: </span><span class="drugName">Abwo | Acnesafe | Acsolve | Bacnil v cream | C mycin | Calinax | Ceda v | Clidavix | Clin v | Clinacin | Clinagel | Clinbet | Clincin | Clinco | Clinda derm | Clinda skin | Clinda V | Clindacef v | Clindacin | Clindamax | Clindanor | Clindasol | Clindopax | Clinmax | Clinxer V | Clycin t | Clycin-v | Dalacin t | Dalacin v | Daymac | Daymac vgl | Gynacin | Uniclin | Vagibact | Veclin</span>;</li>
<li>
<span class="countryCode">(PL)</span> <span class="country">Poland</span><span class="countrySeparator">: </span><span class="drugName">Clindacne | Clindavag | Dalacin | Dalacin t | Klindacin t | Normaclin | Symbactin | Zindaclin</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Cleocin | Cleocin t | Clindagel | Clindamax | Clindesse | Evoclin</span>;</li>
<li>
<span class="countryCode">(PT)</span> <span class="country">Portugal</span><span class="countrySeparator">: </span><span class="drugName">Dalacin v | Zindaclin</span>;</li>
<li>
<span class="countryCode">(PY)</span> <span class="country">Paraguay</span><span class="countrySeparator">: </span><span class="drugName">Clinfol | Divanon | Polipai | Sesil | Vioclin</span>;</li>
<li>
<span class="countryCode">(QA)</span> <span class="country">Qatar</span><span class="countrySeparator">: </span><span class="drugName">Clindacin T | Clinimycin T | Dalacin Ovule | Dalacin T | Dalacin V | Derma-T | Medacin T | Vagiclind | Yenlip</span>;</li>
<li>
<span class="countryCode">(RU)</span> <span class="country">Russian Federation</span><span class="countrySeparator">: </span><span class="drugName">Clindacin | Clindacin prolong | Clindagel | Clindamycin | Clindatop | Clindovit | Clines | Dalacin | Dalacin t</span>;</li>
<li>
<span class="countryCode">(SA)</span> <span class="country">Saudi Arabia</span><span class="countrySeparator">: </span><span class="drugName">Clindasol | Clinimycin T | Dalacin t | Derma-t | Medacin t</span>;</li>
<li>
<span class="countryCode">(SE)</span> <span class="country">Sweden</span><span class="countrySeparator">: </span><span class="drugName">Dalacin | Klindamycin evolan</span>;</li>
<li>
<span class="countryCode">(SG)</span> <span class="country">Singapore</span><span class="countrySeparator">: </span><span class="drugName">Clindagel | Dalacin t | T3 Mycin</span>;</li>
<li>
<span class="countryCode">(SI)</span> <span class="country">Slovenia</span><span class="countrySeparator">: </span><span class="drugName">Dalacin | Dalacin t | Klimicin T | Klimicin V</span>;</li>
<li>
<span class="countryCode">(SK)</span> <span class="country">Slovakia</span><span class="countrySeparator">: </span><span class="drugName">Dalacin | Dalacin c | Dalacin t</span>;</li>
<li>
<span class="countryCode">(TH)</span> <span class="country">Thailand</span><span class="countrySeparator">: </span><span class="drugName">Acny t | Cedelin | Chinacin-t | Clindacne | Clindalin | Clindaman | Klinna | Todacin | Tomei clindai | Vitara Clinda</span>;</li>
<li>
<span class="countryCode">(TR)</span> <span class="country">Turkey</span><span class="countrySeparator">: </span><span class="drugName">Cleocin</span>;</li>
<li>
<span class="countryCode">(TW)</span> <span class="country">Taiwan</span><span class="countrySeparator">: </span><span class="drugName">Aledo | B.B | Cd | Chyndacin | Clear | Clearcin | Cleocin | Cleocin t | Cleodacin | Clinda | Clindamycin | Cliner | Clingene-t | Dalcine | Demaclean | Dermalean | Glinda | Kolincin | Libido | Royalsense | Shuli Qing | Zindaclin</span>;</li>
<li>
<span class="countryCode">(UA)</span> <span class="country">Ukraine</span><span class="countrySeparator">: </span><span class="drugName">Banbakt | Dalacin | Dalacin t | Vagicin</span>;</li>
<li>
<span class="countryCode">(UG)</span> <span class="country">Uganda</span><span class="countrySeparator">: </span><span class="drugName">Clycin-v | Vagibact</span>;</li>
<li>
<span class="countryCode">(UY)</span> <span class="country">Uruguay</span><span class="countrySeparator">: </span><span class="drugName">Clidan | Clindacin | Clintopic | Dalacin v | Vioclin</span>;</li>
<li>
<span class="countryCode">(VE)</span> <span class="country">Venezuela, Bolivarian Republic of</span><span class="countrySeparator">: </span><span class="drugName">Clidets | Clindacin | Clindamicina | Clinfol | Dalacin | Klifer</span>;</li>
<li>
<span class="countryCode">(VN)</span> <span class="country">Viet Nam</span><span class="countrySeparator">: </span><span class="drugName">Azaroin</span>;</li>
<li>
<span class="countryCode">(ZA)</span> <span class="country">South Africa</span><span class="countrySeparator">: </span><span class="drugName">Dalacin t | Dalacin vc</span>;</li>
<li>
<span class="countryCode">(ZM)</span> <span class="country">Zambia</span><span class="countrySeparator">: </span><span class="drugName">C mycin | Pip off</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-11487763">
<a name="11487763"></a>Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. <i>J Pediatr</i>. 2001;139(2):317-319.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/clindamycin-topical-pediatric-drug-information/abstract-text/11487763/pubmed" id="11487763" target="_blank">11487763</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-AAP.1">
<a name="AAP.1"></a>American Academy of Pediatrics (AAP). In: Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH, eds. <i>Red Book: 2021 Report of the Committee on Infectious Diseases</i>. 32nd ed. American Academy of Pediatrics; 2021.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-6810084">
<a name="6810084"></a>Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol—United States. <i>MMWR Morb Mortal Wkly Rep</i>. 1982;31(22):290-291. <a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm" target="_blank">http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm</a>
<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/clindamycin-topical-pediatric-drug-information/abstract-text/6810084/pubmed" id="6810084" target="_blank">6810084</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-6347922">
<a name="6347922"></a>Clemmensen OJ. Topical treatment of hidradenitis suppurativa with clindamycin. <i>Int J Dermatol</i>. 1983;22(5):325-328.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/clindamycin-topical-pediatric-drug-information/abstract-text/6347922/pubmed" id="6347922" target="_blank">6347922</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CleocinT.1">
<a name="CleocinT.1"></a>Cleocin T topical gel, lotion, and solution (clindamycin) [prescribing information]. New York, NY: Pharmacia &amp; Upjohn Co; December 2019.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CleocinT.2">
<a name="CleocinT.2"></a>Cleocin T topical solution (clindamycin) [prescribing information]. New York, NY: Pharmacia &amp; Upjohn; November 2017.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Cleocin.1">
<a name="Cleocin.1"></a>Cleocin vaginal cream (clindamycin) [prescribing information]. New York, NY: Pharmacia &amp; Upjohn; March 2020.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Cleocin.2">
<a name="Cleocin.2"></a>Cleocin vaginal cream (clindamycin) [prescribing information]. New York, NY: Pharmacia &amp; Upjohn; August 2021.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Cleocin.3">
<a name="Cleocin.3"></a>Cleocin vaginal cream (clindamycin) [prescribing information]. New York, NY: Pharmacia &amp; Upjohn; May 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Cleocin.4">
<a name="Cleocin.4"></a>Cleocin vaginal suppository (clindamycin) [prescribing information]. New York, NY: Pharmacia &amp; Upjohn; March 2020.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Cleocin.7">
<a name="Cleocin.7"></a>Cleocin vaginal suppository (clindamycin) [prescribing information]. New York, NY: Pharmacia &amp; Upjohn; July 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Clindacin.1">
<a name="Clindacin.1"></a>Clindacin (clindamycin) [prescribing information]. Fairfield, NJ: Medimetriks Pharmaceuticals, Inc; April 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-ClindacinETZ.1">
<a name="ClindacinETZ.1"></a>Clindacin ETZ (clindamycin) [prescribing information]. Fairfield, NJ: Medimetriks Pharmaceuticals Inc; October 2016.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Clindagel.1">
<a name="Clindagel.1"></a>Clindagel (clindamycin) [prescribing information]. Bridgewater, NJ: Bausch Health US LLC; January 2020.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-EncubeEthicals.1">
<a name="EncubeEthicals.1"></a>Clindamycin Phosphate (topical) [prescribing information]. Durham, NC: Encube Ethicals, Inc; January 2020.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Greenstone.1">
<a name="Greenstone.1"></a>Clindamycin phosphate vaginal cream [prescribing information]. Peapack, NJ: Greenstone LLC; May 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Clinda-T.1">
<a name="Clinda-T.1"></a>Clinda-T (clindamycin) [product monograph]. Laval, Quebec, Canada: Bausch Health, Canada Inc; February 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Clindesse.1">
<a name="Clindesse.1"></a>Clindesse vaginal cream (clindamycin) [prescribing information]. Allegan, MI: Perrigo; November 2014.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Clindesse.2">
<a name="Clindesse.2"></a>Clindesse vaginal cream (clindamycin) [prescribing information]. Allegan, MI: Perrigo; February 2021.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Clindesse.3">
<a name="Clindesse.3"></a>Clindesse (clindamycin) vaginal cream [prescribing information]. Allegan, MI: Padagis; May 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Clindets.1">
<a name="Clindets.1"></a>Clindets pledgets (clindamycin solution) [product monograph]. Mississauga, Ontario, Canada: GlaxoSmithKline Inc; October 2016.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23637225">
<a name="23637225"></a>Eichenfield LF, Krakowski AC, Piggott C, et al. Evidence-based recommendations for the diagnosis and treatment of pediatric acne. <i>Pediatrics</i>. 2013;131 Suppl 3:S163-186.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/clindamycin-topical-pediatric-drug-information/abstract-text/23637225/pubmed" id="23637225" target="_blank">23637225</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Evoclin.1">
<a name="Evoclin.1"></a>Evoclin (clindamycin) foam [prescribing information]. Morgantown, WV: Mylan Pharmaceuticals; April 2018.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-16240515">
<a name="16240515"></a>Faro S, Skokos CK; Clindesse Investigators Group. The efficacy and safety of a single dose of Clindesse vaginal cream versus a seven-dose regimen of Cleocin vaginal cream in patients with bacterial vaginosis. <i>Infect Dis Obstet Gynecol</i>. 2005;13(3):155-160. doi:10.1080/10647440500148321<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/clindamycin-topical-pediatric-drug-information/abstract-text/16240515/pubmed" id="16240515" target="_blank">16240515</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Graber.1">
<a name="Graber.1"></a>Graber E. Acne vulgaris: overview of management. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed February 3, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9024461">
<a name="9024461"></a>"Inactive" ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics (AAP) Committee on Drugs. <i>Pediatrics</i>. 1997;99(2):268-278.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/clindamycin-topical-pediatric-drug-information/abstract-text/9024461/pubmed" id="9024461" target="_blank">9024461</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22236226">
<a name="22236226"></a>Jemec GB. Clinical practice. Hidradenitis suppurativa. <i>N Engl J Med</i>. 2012;366(2):158-164.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/clindamycin-topical-pediatric-drug-information/abstract-text/22236226/pubmed" id="22236226" target="_blank">22236226</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23657872">
<a name="23657872"></a>Kong YL, Tey HL. Treatment of acne vulgaris during pregnancy and lactation. <i>Drugs</i>. 2013;73(8):779-787.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/clindamycin-topical-pediatric-drug-information/abstract-text/23657872/pubmed" id="23657872" target="_blank">23657872</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35675606">
<a name="35675606"></a>Mauck C, Hillier SL, Gendreau J, et al. Single-dose, bioadhesive clindamycin 2% gel for bacterial vaginosis: a randomized controlled trial. <i>Obstet Gynecol</i>. 2022;139(6):1092-1102. doi:10.1097/AOG.0000000000004805<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/clindamycin-topical-pediatric-drug-information/abstract-text/35675606/pubmed" id="35675606" target="_blank">35675606</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-4700555">
<a name="4700555"></a>Philipson A, Sabath LD, and Charles D, "Transplacental Passage of Erythromycin and Clindamycin," <i>N Engl J Med</i>, 1973, 288(23):1219-21.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/clindamycin-topical-pediatric-drug-information/abstract-text/4700555/pubmed" id="4700555" target="_blank">4700555</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Manu.1">
<a name="Manu.1"></a>Refer to the manufacturer's labeling.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19188870">
<a name="19188870"></a>Shehab N, Lewis CL, Streetman DD, Donn SM. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates. <i>Pediatr Crit Care Med</i>. 2009;10(2):256-259.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/clindamycin-topical-pediatric-drug-information/abstract-text/19188870/pubmed" id="19188870" target="_blank">19188870</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-943947">
<a name="943947"></a>Weinstein AJ, Gibbs RS, and Gallagher M, "Placental Transfer of Clindamycin and Gentamicin in Term Pregnancy," <i>Am J Obstet Gynecol</i>, 1976, 124(7):688-91.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/clindamycin-topical-pediatric-drug-information/abstract-text/943947/pubmed" id="943947" target="_blank">943947</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-8425809">
<a name="8425809"></a>Wilkin JK, DeWitt S. Treatment of rosacea: topical clindamycin versus oral tetracycline. <i>Int J Dermatol</i>. 1993;32(1):65-67.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/clindamycin-topical-pediatric-drug-information/abstract-text/8425809/pubmed" id="8425809" target="_blank">8425809</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34292926">
<a name="34292926"></a>Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. <i>MMWR Recomm Rep</i>. 2021;70(4):1-187. doi:10.15585/mmwr.rr7004a1<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/clindamycin-topical-pediatric-drug-information/abstract-text/34292926/pubmed" id="34292926" target="_blank">34292926</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-WHO.1">
<a name="WHO.1"></a>World Health Organization (WHO). Breastfeeding and maternal medication: recommendations for drugs in the eleventh WHO model list of essential drugs. https://apps.who.int/iris/handle/10665/62435. Published 2002.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Xaciato.1">
<a name="Xaciato.1"></a>Xaciato (clindamycin) [prescribing information]. Jersey City, NJ: Organon LLC; December 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26897386">
<a name="26897386"></a>Zaenglein AL, Pathy AL, Schlosser BJ, et al. Guidelines of care for the management of acne vulgaris. <i>J Am Acad Dermatol. </i>2016;74(5):945-973.e33. http://www.jaad.org/article/S0190-9622(15)02614-6/pdf. Accessed March 3, 2022.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/clindamycin-topical-pediatric-drug-information/abstract-text/26897386/pubmed" id="26897386" target="_blank">26897386</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 15954 Version 476.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
